Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Item 2(c) / Item 5 by Quarter
Item 2(c) / Item 5 — Remaining share repurchase authorization at quarter-end ($M) ($M)
Vertex Pharmaceuticals Item 2(c) / Item 5: $2,582M in Q2 2026, down 43.5% from a year earlier.
Where the Q2 2026 figure comes from
“|| Total | 1,033,652 | $ 440.17 | 1,033,652 | $ 2,582,008,580”
Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
Reported in Form 10-Q Part II Item 2(c) & Form 10-K Item 5.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Item 2(c) / Item 5 ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/qtr-buyback-rem-auth
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.